One-Shot gene therapy trial launches for ALS patients
NCT ID NCT07290062
First seen Jan 02, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This early-stage study tests a single injection of INS1202, a gene therapy, given into the spinal fluid of people with ALS. The main goal is to check safety and find the right dose. About 23 adults aged 18 to 79 with either a specific SOD1 gene mutation or no known genetic cause of ALS can join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
USA001
RECRUITINGColumbia, Missouri, 65211, United States
Contact Email: •••••@•••••
-
USA002
RECRUITINGPalo Alto, California, 94304, United States
Contact Email: •••••@•••••
-
USA004
RECRUITINGLa Jolla, California, 92037, United States
Contact Email: •••••@•••••
-
USA006
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact Email: •••••@•••••
-
USA007
RECRUITINGColumbus, Ohio, 43221, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.